Posted On: 10/30/2014 8:16:58 AM
Post# of 46
$NEO Revenues $5.33
called 10/3/13 $3.02
Pr 7 AM 10/30/14
38% increase in Revenue to a Record
Shares Outstanding: 50.17M
Float: 38.50M
Website
Recent trades
64% Buy before revenues Pr
Headlines
Thursday, October 30, 2014
Q3 2014 Neogenomics Inc Earnings Release - Before Market OpenCCBN (Thu 7:07AM EDT)
7:06 am NeoGenomics beats by $0.02, beats on revs; guides Q4 EPS in-line, revs in-lineBriefing.com (Thu 7:06AM EDT)
NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014PR Newswire (Thu 7:00AM EDT)
Wednesday, October 29, 2014
NeoGenomics to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, October 30, 2014Accesswire
Monday, October 27, 2014
NEOGENOMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online
Thursday, October 23, 2014
NeoGenomics is First to Offer Molecular Testing for Resistance to Bruton Tyrosin Kinase Inhibitors for Chronic Lymphocytic LeukemiaPR Newswire
Tuesday, October 21, 2014
Trading EbolaCNBC
Friday, October 17, 2014
NEOGENOMICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, FiEDGAR Online
Thursday, October 16, 2014
NeoGenomics Launches 315 Gene Next Generation Sequencing Test for Solid Tumor Discovery ProfilingPR Newswire
Wednesday, October 15, 2014
NEOGENOMICS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and ExhibitsEDGAR Online
Friday, October 3, 2014
NEOGENOMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online
Wednesday, October 1, 2014
Interim for Neopost SACompany Spotlight
Monday, September 29, 2014
NeoGenomics Appoints Robert J. Shovlin as Chief Operating OfficerPR Newswire
Wednesday, September 24, 2014
NeoGenomics Schedules its Q3 2014 Earnings Release for October 30, 2014PR Newswire
Thursday, August 28, 2014
5 Breakout Stocks Under $10 Set to Soarat TheStreet
Wednesday, August 27, 2014
NEOGENOMICS INC Files SEC form 8-K, Termination of a Material Definitive AgreementEDGAR Online
Friday, August 22, 2014
NEOGENOMICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online
NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment OptionPR Newswire
Friday, August 15, 2014
NEOGENOMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other EventEDGAR Online
NeoGenomics Announces Pricing of $32.2 Million Public OfferingPR Newswire
called 10/3/13 $3.02
Pr 7 AM 10/30/14
38% increase in Revenue to a Record
Shares Outstanding: 50.17M
Float: 38.50M
Website
Recent trades
64% Buy before revenues Pr
Headlines
Thursday, October 30, 2014
Q3 2014 Neogenomics Inc Earnings Release - Before Market OpenCCBN (Thu 7:07AM EDT)
7:06 am NeoGenomics beats by $0.02, beats on revs; guides Q4 EPS in-line, revs in-lineBriefing.com (Thu 7:06AM EDT)
NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014PR Newswire (Thu 7:00AM EDT)
Wednesday, October 29, 2014
NeoGenomics to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, October 30, 2014Accesswire
Monday, October 27, 2014
NEOGENOMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online
Thursday, October 23, 2014
NeoGenomics is First to Offer Molecular Testing for Resistance to Bruton Tyrosin Kinase Inhibitors for Chronic Lymphocytic LeukemiaPR Newswire
Tuesday, October 21, 2014
Trading EbolaCNBC
Friday, October 17, 2014
NEOGENOMICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, FiEDGAR Online
Thursday, October 16, 2014
NeoGenomics Launches 315 Gene Next Generation Sequencing Test for Solid Tumor Discovery ProfilingPR Newswire
Wednesday, October 15, 2014
NEOGENOMICS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and ExhibitsEDGAR Online
Friday, October 3, 2014
NEOGENOMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online
Wednesday, October 1, 2014
Interim for Neopost SACompany Spotlight
Monday, September 29, 2014
NeoGenomics Appoints Robert J. Shovlin as Chief Operating OfficerPR Newswire
Wednesday, September 24, 2014
NeoGenomics Schedules its Q3 2014 Earnings Release for October 30, 2014PR Newswire
Thursday, August 28, 2014
5 Breakout Stocks Under $10 Set to Soarat TheStreet
Wednesday, August 27, 2014
NEOGENOMICS INC Files SEC form 8-K, Termination of a Material Definitive AgreementEDGAR Online
Friday, August 22, 2014
NEOGENOMICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online
NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment OptionPR Newswire
Friday, August 15, 2014
NEOGENOMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other EventEDGAR Online
NeoGenomics Announces Pricing of $32.2 Million Public OfferingPR Newswire
(0)
(0)
